Fauci Confirms Fake COVID Treatment Made Him More Sick,

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
280
Fauci Confirms Fake COVID Treatment Made Him More Sick, Another Fail By Biden’s Administration

On Tuesday, Dr. Anthony Fauci confirmed that he is experiencing “COVID rebound” after taking Pfizer’s Paxlovid, the so-called silver bullet that Biden wasted billions in taxpayer dollars to support.

Paxlovid appears to have almost zero effectiveness for people that are already vaccinated, according to the manufacturer Pfizer’s data.

Fauci, shared his health update while speaking remotely at the Foreign Policy Global Health Forum.

Earlier in June, Fauci tested positive for the virus with mild symptoms, including fatigue. According to Fauci, as his symptoms worsened, he began a five-day course of the supposed wonder drug.

When talking about his experience with the medication, Fauci said that he tested negative for the virus three days in a row. However, when he tested again on the fourth day, the test was positive again.

Fauci said that his symptoms were “much worse” after he tested positive for the second time following the treatment with Paxlovid.


In May, the Centers for Disease Control (CDC) issued a formal warning of a COVID rebound due to a course of Paxlovid.

The CDC said that some patients prescribed Paxlovid suffered a recurrence of symptoms or tested positive for Covid between two and eight days after beginning treatment.

According to a June 22 University of California San Diego School of Medicine study, Covid-19 rebound symptoms after a course of Paxlovid are due to the failure of Pfizer’s wonder drug to impact infected cells and stop viral replication. The study notes that the medication may be rendered useless in vaccinated individuals.

The day after that study was published, Pfizer published its own data from stage 2 drug trials confirming the exact details. The study noted that a fully vaccinated person with a low risk of COVID complications had little to gain from using the drug.

A COVID-positive person allegedly should use Paxlovid to limit symptoms and prevent them from becoming severe enough to require hospitalization. The drug received emergency use authorization in late 2021.

Biden has touted the drug during his 2022 State of the Union address as one of the triumphs of America’s COVID response.

At the 2022 State of the Union, Biden said: “If you get COVID-19, the Pfizer pill reduces your chances of ending up in the hospital by 90 percent.”

“I’ve ordered more pills than anyone in the world has. Pfizer is working overtime to get us a million pills this month and more than double that next month,” he said.


Fauci’s experience seems to verify that of the drug trials, Paxlovid offers little to no benefit for treating the China virus. It is simply another tool used by the big pharmaceutical companies to milk the U.S. government for billions of dollars.

https://www.thegatewaypundit.com/2022/06/watc...istration/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 0

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Zum Drivers Shine as New School Year Begins

Updated Category News Views 1

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Continue Reading
L.L.Bean Teams with Drake and Ann Michael Maye

Updated Category News Views 2

The New Faces of L.L.Bean's Tradition Ah, here we go again with L.L.Bean, spicing things up with a bit of southern flair. This time they've reeled in the Mayes—Drake, that hotshot quarterback from the Patriots, and his better half, Ann Michael. A surprise duo, sure, but that's the kind of refresh the century-old brand could use. They’re all about making New England...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 1

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading
Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 1

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
DUNKMAN's Slam Dunk Expansion Plans for 2027

Updated Category News Views 1

More Than Just A Dunk Contest You ever heard of a slam dunk that turns into something bigger than the game itself? Well, Shaquille O'Neal's DUNKMAN is proving just that. Born from the vision of O'Neal and Authentic Brands Group, this beast of an entity isn't just about dunks anymore—it's a whole darn league carving out space in the sporting world. From Inaugural Sparks...

Continue Reading
Pulnovo's PADN System Revolutionizes PH-LHD Treatment

Updated Category News Views 0

Pulnovo's Breakthrough in Heart Disease Management When Pulnovo Medical rolled out the PADN-HF-PH trial results at the ESC Congress 2026, seasoned investors like me sat up and took note. The trial, hot off the presses in The New England Journal of Medicine, unveiled how Pulmonary Artery Denervation (PADN) is throwing a wrench into the gears of conventional treatment of...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 0

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading
Graphic Packaging Names Berardinelli as HR Executive

Updated Category News Views 1

A New Chapter in HR Leadership at Graphic Packaging September 8 marks a turning point for Graphic Packaging Holding Company with the appointment of Tatiana Berardinelli as their new Chief Human Resources Officer. As NYSE:GPK positions itself for ambitious growth, Berardinelli stands out for her knack for managing transformations and building cultures that thrive in...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 2

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Announcement for MGP Ingredients, Inc. Investors

Updated Category News Views 264

Investigation of MGP Ingredients, Inc. Shares Kessler Topaz Meltzer & Check, LLP is actively investigating potential violations of federal securities laws related to MGP Ingredients, Inc. (NASDAQ: MGPI). This inquiry is particularly aimed at investors who have experienced significant losses and who may have been affected by the company’s revised financial outlook and...

Continue Reading
QinetiQ US Advances Future Capabilities in Army Integration

Updated Category News Views 114

QinetiQ US Advances Battlefield Capabilities QinetiQ US is enhancing battlefield capabilities through its participation in the Future Advanced Long-range Common Optical/Netted-fires Sensor (FALCONS) program. This program plays a pivotal role in advancing target acquisition technologies essential for modern military operations. Innovative System Integration Leveraging its...

Continue Reading
Moe Jeudy-Lamour Launches Innovative Thenar Workout Routine

Updated Category News Views 144

Introducing the Thenar Workout by Moe Jeudy-Lamour Fitness enthusiasts, get ready for a new workout trend that centers around an often-overlooked part of the body: the thumbs! Moe Jeudy-Lamour, renowned for his role in the hit series 'Ted Lasso,' is teaming up with Clean Cult to unveil the Thenar Workout. This innovative approach not only emphasizes thumb strength but is...

Continue Reading
Fannie Mae to Release Financial Results and Host Webcast Event

Updated Category News Views 154

Fannie Mae Plans Financial Results Announcement Fannie Mae, a leader in the mortgage finance industry, has made plans to announce its financial results for the second quarter of 2025. This exciting update will take place before the opening of U.S. financial markets, providing investors with crucial information on the company’s performance. Scheduled Date for Financial...

Continue Reading
The Rise of Radiopharmaceutical CDMO Market and Future Prospects

Updated Category News Views 199

Understanding the Radiopharmaceutical CDMO Market Growth As the medical field increasingly embraces advanced technologies, the Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) market is projected to experience significant growth. According to recent analyses, this market was valued at approximately USD 2.95 billion in the previous year, with...

Continue Reading